Hemogenyx Pharma Plc (HEMO.L) New Corporate Video and Investor Webinar

Hemogenyx Pharmaceuticals plc (LSE: HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases.

Hemogenyx  More Than A Covid-19 Gold Rush Play

Is pleased to announce that a new corporate video is available to view on the Company’s website and can be accessed here

In addition, the Company also announces that Dr Vladislav Sandler, Chief Executive Officer & Co-Founder of Hemogenyx Pharmaceuticals will host a live investor webinar on 20 July 2020 at 16:00 UK time at which he will answer questions about the Company’s current activities.

If you would like to register for the webinar, please follow this link:

https://us02web.zoom.us/meeting/register/tZIocuyrqj4pH9HRgZuobXLJdSDkRXUDFRDU

After registering, you will receive a confirmation email containing information about joining the meeting.

Please submit your questions in advance and not later than 17 July 2020 by emailing hemogenyx@hemogenyx.com .

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

---